Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death
- PMID: 12411391
- DOI: 10.1161/01.res.0000038488.38975.1a
Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death
Abstract
In response to pathophysiological stress, the adult heart undergoes hypertrophic enlargement characterized by an increase in the cross-sectional area of individual myofibers. Although cardiac hypertrophy is initially a compensatory response, sustained hypertrophy is a leading predictor for the development of heart failure. At the molecular level, disease-related stimuli invoke endocrine, paracrine, and autocrine regulatory circuits, which directly influence cardiomyocyte hypertrophy, in part, through membrane bound G protein-coupled receptors and receptor tyrosine kinases. These membrane receptors activate intermediate signal transduction pathways within the cytoplasm such as mitogen-activated protein kinases (MAPKs), protein kinase C (PKC), and calcineurin, which directly modify transcriptional regulatory factors promoting alterations in cardiac gene expression. This review will weigh an increasing body of literature implicating the intermediate signaling pathway consisting of MEK1 and extracellular signal-regulated kinases (ERK1/2) as important regulators of cardiac hypertrophy and myocyte survival. The MEK1-ERK1/2 pathway likely occupies a central regulatory position in the signaling hierarchy of a cardiac myocyte given its unique ability to respond to virtually every characterized hypertrophic agonist and stress stimuli examined to date and based on its ability to promote myocyte growth in vitro and in vivo.
Similar articles
-
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.EMBO J. 2000 Dec 1;19(23):6341-50. doi: 10.1093/emboj/19.23.6341. EMBO J. 2000. PMID: 11101507 Free PMC article.
-
Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.J Mol Cell Cardiol. 2000 Jun;32(6):947-60. doi: 10.1006/jmcc.2000.1135. J Mol Cell Cardiol. 2000. PMID: 10888249
-
Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.Biochem J. 2000 Apr 1;347 Pt 1(Pt 1):275-84. Biochem J. 2000. PMID: 10727428 Free PMC article.
-
Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.Cardiovasc Res. 2004 Aug 15;63(3):467-75. doi: 10.1016/j.cardiores.2004.01.021. Cardiovasc Res. 2004. PMID: 15276472 Review.
-
Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?Pharmacol Res. 2010 Nov;62(5):365-83. doi: 10.1016/j.phrs.2010.07.003. Epub 2010 Jul 17. Pharmacol Res. 2010. PMID: 20643208 Review.
Cited by
-
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth.Br J Pharmacol. 2013 Jan;168(2):296-317. doi: 10.1111/j.1476-5381.2012.02195.x. Br J Pharmacol. 2013. PMID: 22946456 Free PMC article. Review.
-
TNF-alpha-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy.J Cell Mol Med. 2010 Jul;14(7):1988-97. doi: 10.1111/j.1582-4934.2009.00904.x. Epub 2009 Sep 14. J Cell Mol Med. 2010. PMID: 19754666 Free PMC article.
-
Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure.Physiol Genomics. 2005 Sep 21;23(1):18-27. doi: 10.1152/physiolgenomics.00061.2005. Epub 2005 Jul 20. Physiol Genomics. 2005. PMID: 16033866 Free PMC article.
-
miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling.Oxid Med Cell Longev. 2019 Sep 12;2019:8768164. doi: 10.1155/2019/8768164. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31612078 Free PMC article.
-
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art Review.JACC CardioOncol. 2022 Mar 15;4(1):1-18. doi: 10.1016/j.jaccao.2022.01.096. eCollection 2022 Mar. JACC CardioOncol. 2022. PMID: 35492830 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous